phacidin has been researched along with 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid in 1 studies
| Studies (phacidin) | Trials (phacidin) | Recent Studies (post-2010) (phacidin) | Studies (2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid) | Trials (2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid) | Recent Studies (post-2010) (2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 11 | 0 | 2 |
| Protein | Taxonomy | phacidin (IC50) | 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 18.81 | |
| SUMO-1 | Homo sapiens (human) | 2.2735 | |
| Mcl-1 | Homo sapiens (human) | 1.1863 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 26.7 | |
| small ubiquitin-related modifier 2 isoform b precursor | Homo sapiens (human) | 3.125 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 18.2 | |
| fatty acid synthase | Homo sapiens (human) | 7.145 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 18.2 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 41.42 | |
| Vif | Human immunodeficiency virus 1 | 0.94 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.94 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.85 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.85 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.85 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.85 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.85 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | 7.6 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | 7.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorjsuren, D; Egli, M; Eoff, RL; Jadhav, A; Lloyd, RS; Maloney, DJ; Simeonov, A; Yamanaka, K | 1 |
1 other study(ies) available for phacidin and 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid
| Article | Year |
|---|---|
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Topics: Acrolein; Benzimidazoles; Biphenyl Compounds; Cell Line, Transformed; Cell Survival; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Nucleic Acid Synthesis Inhibitors; Small Molecule Libraries; Terpenes; Tetrazoles; Ultraviolet Rays | 2012 |